Pathophysiology and possible treatments for olfactory-gustatory disorders in patients affected by COVID-19

SARS-CoV-2 infects host cells mainly through the interaction between the virus's Spike protein and the viral receptors namely Angiotensin-Converting Enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2). Both are highly expressed in the gastrointestinal tract, in the nasal and bronchial...

Full description

Bibliographic Details

Published in:	Current Research in Pharmacology and Drug Discovery
Main Authors:	Francisca Idalina Neta, Amélia Carolina Lopes Fernandes, Adson José Martins Vale, Francisco Irochima Pinheiro, Ricardo Ney Cobucci, Eduardo Pereira de Azevedo, Fausto Pierdoná Guzen
Format:	Article
Language:	English
Published:	Elsevier 2021-01-01
Subjects:	COVID-19 Smell Taste Anosmia Ageusia Therapeutics
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590257121000225